MONTPELLIER, France — August 28, 2026 — Lupin Dental SAS, an early-stage robotics company based in France and focused on developing innovative dental technologies, today announced the successful close of its €15 million Series A financing round, led by Fynveur, a long-term private equity investment company advised by Invus.
We are delighted to announce the successful closing of Lupin Dental’s €15 million Series A financing round, marking a significant milestone in our growth journey.
The round was led by Fynveur, with a €10 million investment, alongside the continued support of our existing shareholders. We are also pleased to welcome new private investors who share our vision and ambition to transform the future of dental care. The financing is further complemented by a loan from Bpifrance, providing additional support as we enter our next phase of growth.
“Lupin Dental opens a new chapter with this important milestone,” said co-founders Galip Gürel and Stefen Koubi. “It reflects our investors’ confidence in our vision and enables us to accelerate our mission to transform dental care through innovation.”
Fynveur’s participation marks a significant milestone for the Company as it enters its next phase of growth. With extensive experience supporting high-potential businesses, Fynveur, together with its advisor, Invus, will partner closely with Lupin Dental to provide strategic guidance, support the Company’s operations, and strengthen its position in the field of next-generation dental robotics. Invus will also join the Board of Lupin Dental.
About Lupin Dental
Lupin Dental SAS is a pioneering company specializing in cutting-edge dental robotics, headquartered in Montpellier, France. The company was founded by two of the world’s most renowned and respected dentists in the field of aesthetic dentistry, Dr. Galip Gürel and Dr. Stefen Koubi.
Lupin Dental was founded to bring the benefits of supervised automation to veneers and other complex dental treatments. The Lupin® Robotic System is a supervised automated robotic platform for minimally invasive tooth preparation procedures for aesthetic veneers.
The Lupin® Robotic System is approved for clinical use in India and the United Kingdom. It is not currently approved for clinical use in the USA or EU. The Lup® Robotic System technology is licensed to Dolphin Lifesciences LLC and is manufactured and distributed in India as Dolphin Robotic Dental System.
As part of its ongoing commitment to innovation, Lupin Dental plans to expand partnerships with leading academic and medical institutions, as well as dental professionals, including individual dentists and Dental Service Organizations (DSOs) to support the widespread adoption of its robotic technology.
For more information: https://lupindental.com
Media Contacts: oliviert@lupindental.com